西点药业拟最高5000万元回购股份用于员工激励

Group 1 - The company, Xiduan Pharmaceutical, has announced a share repurchase plan with a total amount between 25 million and 50 million yuan, at a price not exceeding 42 yuan per share, aimed at employee stock ownership or equity incentives [1][2] - The repurchase will be conducted through centralized bidding and is set to occur within 12 months from the board's approval [2] - Financial data indicates that for the first three quarters of 2025, the company's operating revenue decreased by 1.89% year-on-year, and the net profit attributable to shareholders fell by 2.70% year-on-year [3]